What is China National Accord Medicines Cash Flow from Financing?
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2024,
China National Accord Medicines paid¥0 Mil more to buy back shares than it received from issuing new shares.
It received¥72 Mil from issuing more debt.
It paid¥0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spent¥60 Mil paying cash dividends to shareholders.
It received¥106 Mil on other financial activities.
In all, China National Accord Medicinesearned¥119 Mil on financial activities for the
three
months ended in Mar. 2024.
China National Accord Medicines Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China National Accord Medicines Cash Flow from Financing Chart
China National Accord Medicines Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-2,206 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Accord Medicines (SZSE:000028) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
China National Accord Medicines's issuance of stock for the
three
months ended in Mar. 2024 was ¥0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
China National Accord Medicines's repurchase of stock for the
three
months ended in Mar. 2024 was ¥0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
China National Accord Medicines's net issuance of debt for the
three
months ended in Mar. 2024 was ¥72 Mil.
China National Accord Medicines received¥72 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
China National Accord Medicines's net issuance of preferred for the
three
months ended in Mar. 2024 was ¥0 Mil.
China National Accord Medicines paid¥0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
China National Accord Medicines's cash flow for dividends for the
three
months ended in Mar. 2024 was ¥-60 Mil.
China National Accord Medicines spent¥60 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
China National Accord Medicines's other financing for the
three
months ended in Mar. 2024 was ¥106 Mil.
China National Accord Medicines received¥106 Mil on other financial activities.
China National Accord Medicines Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of China National Accord Medicines's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
China National Accord Medicines (SZSE:000028) Business Description
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:000028 has been successfully added to your 